Spanish cardiac surgery audit promises QA drive
This article was originally published in Clinica
The cardiac surgery unit of Spain's Hospital Universitario de Canarias (HUC), in Tenerife, has denounced as defamatory headlines and comments in relation to allegations that it is responsible for abnormally high death rates. But, whatever the outcome of any prospective legal action, the data on the unit's activity in 2005 and 2006, as reported by daily El Pais, can only trigger a tightening of surgical quality and outcomes monitoring, at a regional if not national level.
You may also be interested in...
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.